Dominique Figarella-Branger
Dominique Figarella-Branger
Affiliation inconnue
Adresse e-mail validée de
Citée par
Citée par
The 2016 World Health Organization classification of tumors of the central nervous system: a summary
DN Louis, A Perry, G Reifenberger, A Von Deimling, D Figarella-Branger, ...
Acta neuropathologica 131 (6), 803-820, 2016
I nternational S ociety of N europathology‐H aarlem C onsensus G uidelines for N ervous S ystem T umor C lassification and G rading
DN Louis, A Perry, P Burger, DW Ellison, G Reifenberger, A von Deimling, ...
Brain pathology 24 (5), 429-435, 2014
New brain tumor entities emerge from molecular classification of CNS-PNETs
D Sturm, BA Orr, UH Toprak, V Hovestadt, DTW Jones, D Capper, M Sill, ...
Cell 164 (5), 1060-1072, 2016
OPA1 mutations induce mitochondrial DNA instability and optic atrophy ‘plus’ phenotypes
P Amati-Bonneau, ML Valentino, P Reynier, ME Gallardo, B Bornstein, ...
Brain 131 (2), 338-351, 2008
Central neurocytoma: a synopsis of clinical and histological features
J Hassoun, F Söylemezoglu, D Gambarelli, D Figarella‐Branger, ...
Brain Pathology 3 (3), 297-306, 1993
A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up
J Trouillas, P Roy, N Sturm, E Dantony, C Cortet-Rudelli, G Viennet, ...
Acta neuropathologica 126 (1), 123-135, 2013
Pilocytic astrocytomas in children: prognostic factors—a retrospective study of 80 cases
C Fernandez, D Figarella-Branger, N Girard, C Bouvier-Labit, J Gouvernet, ...
Neurosurgery 53 (3), 544-555, 2003
Macrophagic myofasciitis: an emerging entity
RK Gherardi, M Coquet, P Chérin, FJ Authier, P Laforêt, L Belec, ...
The Lancet 352 (9125), 347-352, 1998
Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis
S Rutkowski, K Von Hoff, A Emser, I Zwiener, T Pietsch, ...
Journal of clinical oncology 28 (33), 4961-4968, 2010
Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis
P Metellus, B Coulibaly, C Colin, AM de Paula, A Vasiljevic, D Taieb, ...
Acta neuropathologica 120 (6), 719-729, 2010
Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial
B Lannering, S Rutkowski, F Doz, B Pizer, G Gustafsson, A Navajas, ...
Journal of clinical oncology 30 (26), 3187-3193, 2012
Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes
K Nguyen, G Bassez, M Krahn, R Bernard, P Laforêt, V Labelle, ...
Archives of neurology 64 (8), 1176-1182, 2007
Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA
C Huxley, E Passage, A Manson, G Putzu, D Figarella-Branger, ...
Human molecular genetics 5 (5), 563-569, 1996
Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts
DW Ellison, M Kocak, D Figarella-Branger, G Felice, G Catherine, ...
Journal of negative results in biomedicine 10 (1), 1-13, 2011
Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide
OL Chinot, M Barrie, S Fuentes, N Eudes, S Lancelot, P Metellus, ...
Journal of Clinical Oncology 25 (12), 1470-1475, 2007
Pineal region tumors and the role of stereotactic biopsy: review of the mortality, morbidity, and diagnostic rates in 370 cases
J Regis, P Bouillot, F Rouby-Volot, D Figarella-Branger, H Dufour, ...
Neurosurgery 39 (5), 907-914, 1996
Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience
G Raverot, N Sturm, F De Fraipont, M Muller, S Salenave, P Caron, ...
The Journal of Clinical Endocrinology & Metabolism 95 (10), 4592-4599, 2010
Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease
S Bilodeau, S Vallette-Kasic, Y Gauthier, D Figarella-Branger, T Brue, ...
Genes & development 20 (20), 2871-2886, 2006
Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomas
A Gonzalez-Aguilar, A Idbaih, B Boisselier, N Habbita, M Rossetto, ...
Clinical cancer research 18 (19), 5203-5211, 2012
Stereoelectroencephalography in presurgical assessment of MRI-negative epilepsy
A McGonigal, F Bartolomei, J Régis, M Guye, M Gavaret, ATD Fonseca, ...
Brain 130 (12), 3169-3183, 2007
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20